3-Methylpyridine

We are 3-Methylpyridine CAS:108-99-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 108-99-6
Product Name: 3-Methylpyridine
Other Name:
3-Methylpyridine
3-Mepy
β-Picoline
3-Picoline
 
Density: 0.9±0.1 g/cm3
Boiling Point: 143.5±3.0 °C at 760 mmHg
Melting Point: −19 °C(lit.)
Molecular Formula: C6H7N
Molecular Weight: 93.127
Flash Point: 36.1±0.0 °C
Exact Mass: 93.057846
PSA: 12.89000
LogP: 1.19
Vapour density: 3.2 (vs air)
Vapour Pressure: 6.7±0.3 mmHg at 25°C
Index of Refraction: 1.501
Stability: Stable. Flammable. Hygroscopic. Incompatible with oxidizing agents.
Water Solubility: soluble
 
Specification
Appearance: Yellowish transparent liquid
Assay: ≥99.0%
4-Picoline: ≤0.8%
3,5-Lutidine: ≤0.1%
Water: ≤0.5%
 
Application
Intermediates of Acetaniprid CAS: 135410-20-7.
Intermediates of Imidacloprid CAS: 138261-41-3.
Be used as pesticide intermediate.
Mainly be used in the manufacture of vitamin B6, nicotinic acid and nicotinamide, nicolamin and cardiotonics; it can also be used as a solvent, niacin, nicotinamide, nicolazine, alcohol denaturant, dye intermediate, resin intermediate, raw materials for rubber vulcanization accelerators, pesticides, waterproofing agents, and additives for film sensitizers. Applicationd as a solvent in organic synthesis and for the preparation of nicotine and nicotinamide.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

3-Methylpyridine


Related News: Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body.(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride CAS:477600-68-3 Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body.35250-53-4 The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.2-[(Diphenylmethyl)Thio]Acetamide INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.

Related Products
Product Name
2-piperazin-1-ylpyrimidine,hydrochloride View Details
4-bromobutan-1-ol View Details
2-(2-bromoethoxy)-1,3,5-trichlorobenzene View Details
2,2-Difluoro-2-(fluorosulfonyl)acetic acid Cas:1717-59-5 manufacturer Tetrabutylammonium periodate Cas:65201-77-6 manufacturer (R)-(-)-Pyrrolidine-3-carboxylic Acid manufacturer 2-Deoxy-L-ribose manufacturer 6-Methyl-2-(4-methylphenyl)imidazo[1,2-a]-pyridine-3-acetic acid manufacturer